Applitech's system engineers design and commission customized S88-compliant batch and continuous process control systems for pharmaceutical, specialty chemical, and biotechnology manufacturers. Each installation is engineered to ensure absolute product quality and full compliance with FDA regulations, while supporting the rapid evolution of process formulations these industries require.
Overview
Applitech has always built its industrial control systems on non-proprietary, open architectures. The ANSI/ISA-88 (S88) compliant control systems implemented by Applitech engineers have proven effective at sustaining flexible cGMP operations across batch, discrete, and continuous industries, with a modular structure and standard terminology that improves cross-functional communication.
Application areas
- 01Pharmaceutical batch and continuous processing
- 02Specialty chemical and biotech manufacturing
- 03Industrial building automation, clean room, HVAC, and utilities
- 04Municipal water and wastewater treatment
- 05DeltaV, iBatch, and other S88 installations
- 06FDA-validated systems compliant with 21 CFR Part 11
Technical background and project management
- 01Initial engineering, electrical and field instrumentation design
- 02Control panel fabrication and system configuration
- 03Loop checkout, testing, commissioning, and start-up
- 04Library of more than 75 pre-configured, validated DeltaV batch phases
- 05Functional Requirement Specifications for each client
- 06Thin Client Networks, Batch Application Servers, VPN remote access
- 07Complex I/O networks: ASI, Profibus, Fieldbus, DeviceNet, serial
- 08Self-diagnostic and field troubleshooting tools, PI Historian integration
- 09Customized Access and SQL queries against the Batch Historian
Why Applitech for pharmaceutical control
Pharmaceutical process control is unforgiving on regulatory grounds and demanding on engineering grounds. Applitech engineers carry both the cGMP discipline and the S88 fluency required, with project economics that customers can defend to their finance teams and validation programs that hold up under FDA inspection.